[Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)].
In the aging brain, there is an alteration of neurotransmettor systems, essentially catecholaminergics (dopamine, noradrenaline). The experimental works which show the agonist effect of piribedil on cerebral dopaminergic systems are presented. The results of the action of piribedil in the cerebral neuro-vascular syndrom are analysed.
D000368:Aged; D000818:Animals; D001927:Brain Diseases / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D009434:Neural Pathways / Q000187:drug effects; D010879:Piperazines / Q000627:therapeutic use*; D010891:Piribedil / Q000627:therapeutic use*; D051381:Rats; D013577:Syndrome
D010879:Piperazines; D010891:Piribedil
Piribédil, agoniste dopaminergique et syndrome cérébral neuro-vasculaire du sujet âgé. Résultats d'un essai thérapeutique.